Skip to main content
Back to Gaingels

Gaingels's Biotechnology Portfolio

Browse 16 Biotechnology companies funded by Gaingels. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
16
Total Funding in Biotechnology
$339.1M

Biotechnology Portfolio Companies (16)

Export
BiotechnologyLife Science

Mapping interactions foundational to therapeutic discovery and human health.

Monmouth Junction, United States
May 2026
$12.5M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyGeneticsTherapeutics

Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.

Philadelphia, United States
May 2026
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyTherapeutics

Swing Therapeutics provides digital therapeutics for people with chronic conditions.

San Francisco, United States
May 2026
Grant

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyEmergency MedicineHealth CareMachine Learning

Future Fertility is a provider of artificial intelligence tools for reproductive medicine.

Toronto, Canada
April 2026
Series A

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyRobotics

twig bio operates as a bioengineering startup.

London, United Kingdom
April 2026
Grant

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyLife ScienceTherapeutics

Alloy Therapeutics is a biotechnology company that provides drug discovery services to support the development of therapeutic biologics.

Waltham, United States
April 2026
Series E

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical Device

Ossium Health builds a bone marrow bank to treat blood cancers.

San Francisco, United States
April 2026
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalMental HealthPharmaceutical

Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company that develops psychedelic and related drugs to treat mental illnesses.

New York, United States
March 2026
$60.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareInformation Technology

ImmuneBridge is developing allogeneic immunotherapies for cancer.

San Francisco, United States
March 2026
$7.7M
Seed

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyNeurosciencePrecision Medicine

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Los Altos, United States
March 2026
$120.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife Science

Glyphic Biotechnologies is a biotechnology company that develops a protein sequencing platform.

New York, United States
September 2025
$38.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeuroscience

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

Boston, United States
September 2025
$25.0M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyGeneticsLife Science

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

New York, United States
August 2025
$44.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical Device

Cooler Heads develops a portable scalp cooling system designed for chemotherapy patients.

San Diego, United States
July 2025
$11.0M
Series A

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife SciencePharmaceutical

Synfini is a drug discovery platform combining AI, chemistry automation, and cloud tools to design improved molecules.

Menlo Park, United States
July 2025
$8.9M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth Care

Biostate AI develops generative AI that benefit all human health.

Palo Alto, United States
May 2025
$12.0M
Series A

Founder Contacts

19,000+ verified contacts

Explore Gaingels's Full Portfolio

View all companies funded by Gaingels across every industry and funding stage.

View Full Gaingels Portfolio